ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • ACR Convergence 2026
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2013

Abstract Number: 2552

Predictive Significance Of ANTI-Prothrombin Antibodies For Second and Third Trimester Obstetric Complications In Patients With Systemic LUPUS Erythematosus and ANTI-Phospholipid Syndrome

Marta Mosca1, Chiara Tani2, Martina Fabris3, Francesca Strigini4, Linda Carli1, Sabrina Vagnani5, Rosaria Talarico6, Chiara Baldini7, Alessandra Della Rossa8, Elio Tonutti9 and Stefano Bombardieri1, 1Rheumatology Unit, University of Pisa, Pisa, Italy, 2Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, 3Institute of Clinical Pathology, Udine, Italy, 4University of Pisa, Pisa, Italy, 5Department of Clinical and Experimental Medicine, Rheumatology Unit, University of Pisa, Pisa, Italy, 6Rheumatology Unit, Pisa, Italy, 7University of Pisa, Rheumatology Unit, Pisa, Italy, 8Clinical and Experimental Medicine, Rheumatology Unit, Pisa, Italy, 9Santa Maria Hospital, Udine, Italy

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2013

Keywords: APL, pregnancy and systemic lupus erythematosus (SLE)

Session Information

Title: Systemic Lupus Erythematosus-Clinical Aspects III: Biomarkers, Quality of Life and Disease Indicators, Late Complications

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Anti-prothrombin antibodies (aPT) either alone or in association with other anti-phospholipid antibodies have been associated with an increased risk of thrombosis as well as of adverse obstetric outcomes particularly, recurrent early miscarriages.To assess whether anti-prothrombin antibodies have a predictive significance for the occurrence of late obstetric complications and maternal events in patients with SLE and APS

Methods:

Sera from pregnant patients with SLE and APS collected during the first trimester of pregnancy were examined for the presence of anti-prothrombin antibodies (aPT), anticardiolipin antibodies (aCL), anti-B2GPI antibodies, Lupus anticoagulant (LA). Pregnancies were prospectively followed. The following obstetric complications were considered: preterm delivery, pre-eclampsia, eclampsia, intrauterine growth retardation, intrauterine fetal death. In addition the occurrence of maternal thrombotic complications was recorded.

Results:

Seventy six pregnancies in 60 patients (18 APS and 52 SLE) with a duration >10 weeks were included in the analysis. Anti-phospholipid antibodies were positive in 26 patients (aCL 25, LA 17, aPT 16 , anti- B2GPI 6). Pregnancy outcomes are reported in the table 1.

A significant correlation was observed between the presence of anti-prothrombin antibodies and the occurrence of obstetric complications (p<0.05). The positivity of anti-prothrombin antibodies in addition to either positive aCL, anti-B2GPI and/or LA increased the risk of developing late obstetric complications (p< 0.001). No correlations were observed between the presence of anti-prothrombin antibodies alone or multiple anti-phospholipid antibodies and the occurrence of maternal thrombotic events.

Conclusion:

The presence of aPT antibodies appears associated with an increased risk for late obstetric complications in SLE and APS and therefore their assessment is suggested in these patients at the beginning of pregnancy.

 

SLE

APS

Whole group

IUFD

2

3

5

Perinatal death

0

1

1

Preterm delivery

17

12

29

IUGR

7

1

8

Pre-eclampsia

7

4

11

HELLP

0

2

2

Maternal thrombotic manifestations

2

3

5


Disclosure:

M. Mosca,
None;

C. Tani,
None;

M. Fabris,
None;

F. Strigini,
None;

L. Carli,
None;

S. Vagnani,
None;

R. Talarico,
None;

C. Baldini,
None;

A. Della Rossa,
None;

E. Tonutti,
None;

S. Bombardieri,
None.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictive-significance-of-anti-prothrombin-antibodies-for-second-and-third-trimester-obstetric-complications-in-patients-with-systemic-lupus-erythematosus-and-anti-phospholipid-syndrome/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology